Efficacy of short-duration Furazolidone in two different quadruple regimens for H. pylori eradication

Fakheri, Hafez Tirgar; Fakhri, Moloud; Shahmohammadi, Soheila
July 2011
Pakistan Journal of Medical Sciences;Jul2011, Vol. 27 Issue 4, p887
Academic Journal
Objective: To assess the efficacy and tolerability of using high dose Furazolidone just during the first week of two different quadruple regimens in eradicating H. pylori. Methodology: One-hundred sixty patients with duodenal ulcer and positive H. pylori infection were randomly allocated into two groups. Group A received (OAM-F) omeprazole (20 mg BID), amoxicillin (1gr BID), metronidazole (500mg BID) for two weeks and Furazolidone (200 mg BID) just during the first week. Patients in group B received (OAB-F) omeprazole (20 mg BID), amoxicillin (1 gr BID), bismuth subcitrate (240 mg BID) for two weeks and Furazolidone (200 mg BID) in the first week. Results: The eradication rates by per-protocol and intention-to-treat analyses were 86.36% and 80% in group A and 90.27% and 86.3% in group B, respectively. Severe side effects of the drugs were more prevalent in group A compared with group B (12.8% against 2.5% ) Conclusions: One-week Furazolidone combined with two-week Omeprazole, amoxicillin and bismuth subcitrate is a safe and cost effective regimen to eradicate of H pylori infection in Iran


Related Articles

  • Short-Duration Furazolidone Therapy in Combination with Amoxicillin, Bismuth Subcitrate, and Omeprazole for Eradication of Helicobacter pylori. Hasan, Salman R.; Vahid, Vahabzadeh; Reza, Pahlvanzadah M.; Roham, Salman R. // Saudi Journal of Gastroenterology;Jan2010, Vol. 16 Issue 1, p14 

    Background/Aim: Resistance to metronidazole is one of the most common reasons for Helicobacter pylori treatment failure with the classic triple therapy. The clarithromycin-based regimen is not cost-effective for use in developing countries. Though furazolidone is a great substitute it has many...

  • Efficacy and Safety of Helicobacter pylori Eradication Therapy with Omeprazole, Amoxicillin and High- and Low-Dose Clarithromycin in Japanese Patients: A Randomised, Double-Blind, Multicentre Study. Higuchi, Kazuhide; Maekawa, Takama; Nakagawa, Koichiro; Chouno, Shinji; Hayakumo, Takanobu; Tomono, Naomi; Orino, Akio; Tanimura, Hirohisa; Asahina, Kan; Matsuura, Naotaka; Endo, Motohiko; Hirano, Masanori; Sakamoto, Choitsu; Inomoto, Tsutomu; Arakawa, Tetsuo // Clinical Drug Investigation;2006, Vol. 26 Issue 7, p403 

    OBJECTIVE: Seven-day administration of omeprazole 40 mg/day + amoxicillin 1500 mg/day + clarithromycin 800 mg/day is currently approved in Japan for the eradication of Helicobacter pylori infection. We investigated the efficacy and safety of an omeprazole-based triple therapy regimen in...

  • Short-- and Long--Term Omeprazole for the Treatment and Prevention of Duodenal Ulcer, and Effect on Helicobacter pylori. Marzio, L.; Biasco, G.; Cifani, F.; DeFanis, C.; Falcucci, M.; Ferrini, G.; Grossi, L.; Iannetti, G.; Larcinese, G.; Lattanzio, R.; Lauri, A.; Masciulli, V.; Sacco, T.; Sciampa, G.; Sedici, A.; Semperlotti, N.; Spadaccini, A. // American Journal of Gastroenterology;Dec1995, Vol. 90 Issue 12, p2172 

    Objective: This study analyzes the effect of short- and long-term omeprazole (OM) on duodenal ulcer healing. recurrence, and H. pylori status. Methods: Patients affected by active duodenal ulcer were randomly allocated to treatment with OM 20 mg or 40 mg once daily for 4 wk. Subsequently,...

  • Cost-Effectiveness of Treatment Regimens for the Eradication of Helicobacter pylori in Duodenal Ulcer. Vakil, Nimish; Fennerty, M. Brian // American Journal of Gastroenterology;Feb1996, Vol. 91 Issue 2, p239 

    Background: Eradication of Helicobacter pylori with antimicrobials was recommended by a recent NIH consensus panel for all infected patients with peptic ulcer disease. The precise regimen that should be used for eradication of the infection remains uncertain because of the variety of...

  • The Influence of Drug Dosage on Helicobacter pylori Eradication: A Cost-Effectiveness Analysis. Treiber, Gerhard // American Journal of Gastroenterology;Feb1996, Vol. 91 Issue 2, p246 

    Objectives: This review provides an updated overview on Helicobacter pylori (HP) trials, focusing on drug dosage and cost:benefit ratio. Methods: Literature review, with analysis of 362 treatments with 13,562 patients. Results: Statistical evaluation demonstrated the following mean HP...

  • Quadruple therapy with furazolidone for retreatment in patients with peptic ulcer disease. Gonçalves Felga, Guilherme Eduardo; Silva, Fernando Marcuz; Barbuti, Ricardo Correa; Navarro-Rodriguez, Tomás; Zaterka, Schlioma; Eisig, Jaime Natan; Jia-Yu Xu // World Journal of Gastroenterology;10/28/2008, Vol. 14 Issue 40, p6224 

    AIM: To establish the efficacy and safety of a 7-d therapeutic regimen using omeprazole, bismuth subcitrate, furazolidone and amoxicillin in patients with peptic ulcer disease who had been previously treated with other therapeutic regimens without success. METHODS: Open cohort study which...

  • Is Raised Helicobacter pylori Antibody Titre Enough to Decide Retreatment? Bibi, Safia; Ahmed, Waquaruddin; Arif, Ambreen; Alam, Syed Ejaz // Pakistan Journal of Medical Research;Jul2011, Vol. 50 Issue 3, p101 

    Background: Helicobacter pylori infection causes a rise in its antibodies which take almost a year to come to baseline following successful eradication treatment. Checking these values in between a year may give falsely high values and many patients may thus be over treated. Aims: To serially...

  • Efficacy and Tolerability of Three Regimens for Helicobacter pylori Eradication: A Multicentre, Double-Blind, Randomised Clinical Trial. Bujanda, Luis; Herrerias, Juan M.; Ripolles, Vicente; Pena, Delfim; Chavesdacruz, Antonio; Chavez-da-Cruz, Antonio; Teixeira, Carlos; Company, Teresa; Fueyo, Arturo // Clinical Drug Investigation;2001, Vol. 21 Issue 1, p1 

    Objective: Helicobacter pylori plays a pivotal role in gastroduodenal disease. Ranitidine bismuth citrate (RBC)-based triple therapies for a period of 7 days have proven to be an effective treatment for H. pylori The aim of this study was to compare the eradication efficacy and tolerability...

  • Omeprazole 40 mg o.m. Combined with Amoxycillin Alone or with Amoxycillin and Metronidazole in the Eradication of Helicobacter pylori. Goh, K. L.; Peh, S. C.; Parasakthi, N.; Wong, N. W.; Tan, K. K.; Lo, Y. L. // American Journal of Gastroenterology;Oct1994, Vol. 89 Issue 10, p1789 

    Objectives: Our objectives were to determine the effect of dual therapy with omeprazole and amoxicillin and of triple therapy with omeprazole, amoxicillin, and metronidazole in the eradication of Helicobacter pylori (HP) and to study the long-term results of eradication in these patients....


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics